Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Knowing when and how to realign your budget is crucial for maintaining financial stability. Explore the best practices to ensure timely adjustments.
28,655 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A regional bank stock year delivered a solid 14% gain even as a large investor trimmed holdings by roughly $2.6 milli...
A recent SEC filing shows Marshall Investment Management adding a sizable stake to the TCW Flexible Income ETF (FLXR)...
Mara Holdings faced a tough trading day as its stock slumped amid disappointing earnings and swinging crypto prices. ...
Berkshire Hathaway’s massive cash pile has long frustrated investors. Now the company is finally putting some of that...
A director quietly sold a notable stake in American Superconductor, prompting questions about what it signals for inv...
A high-profile insider move can ripple through a stock's story. This article breaks down the C3.ai CEO's $4.2 million...
When a founder sells a portion of stock, investors often wonder if it signals trouble or opportunity. This deep dive ...
AI-driven recommendations are shaping what travelers expect before they even land on a hotel page. Brands now face a ...
Savers face a rate tug-of-war in 2026 as money market accounts high yields compete with high yield savings accounts. ...
A board director at Veracyte sold shares after a substantial stock run. This guide shows you how to interpret insider...
A Flywire director recently sold 6,524 shares. This guide explains what insider moves mean, how to read Form 4 data, ...